TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

2.80$ -1.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Adagene Inc (ADAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 134 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADAG
Line item Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q2 25 Q4 25 Q1 26 Q2 26
54 – – – 106 98 98 89 84 218 218 190 190 179 179 152 152 135 135 116 116 101 101 101 89 67 78 78 134
52 – – – 104 97 97 87 79 215 215 186 186 175 175 149 149 133 133 113 113 99 99 99 88 65 77 77 132
16 – – – 93 93 93 83 75 208 208 174 174 168 168 144 144 129 129 110 110 96 96 96 85 63 75 75 128
49 – – – 101 93 93 83 75 208 208 174 174 168 168 144 144 129 129 110 110 96 96 96 85 63 – 75 128
1.4 – – – 2.1 0.8 0.8 0.4 0.1 0.6 1.5 3.0 7.5 7.5 1.9 0.6 0.6 0.6 0.4 – 0.2 – 0.0 0.0 0.0 0.0 – 0.0 0.2
– – – – 0.0 – – – – 0.0 0.0 0.0 – 0.0 – – – – – – – – 0.0 0.0 – – – – –
– – – – 1.9 1.7 1.7 1.8 2.1 2.6 2.6 3.5 3.5 3.5 3.5 3.0 3.0 2.5 2.5 – – – – – – – – – –
95 – – – 163 12 12 14 174 32 32 33 33 66 66 69 69 53 53 45 45 44 44 44 39 29 43 43 28
10 – – – 7.2 11 11 10 16 30 30 30 30 56 56 55 55 39 39 31 31 40 40 40 38 29 25 25 26
2.3 – – – 1.0 2.6 2.6 3.1 5.0 5.7 5.7 4.5 4.5 7.6 7.6 14 14 12 12 8.6 8.6 16 16 16 18 6.8 – 5.1 4.9
0.6 – – – 0.7 1.2 1.2 1.2 1.8 2.8 2.8 3.3 3.3 4.7 4.7 3.7 3.7 4.5 4.5 3.1 3.1 3.4 3.4 3.4 4.2 3.6 2.9 2.9 16
– – – – 1.5 – – 3.1 3.0 – 2.0 – 3.0 – 9.3 – 14 – 13 – 14 – 4.6 – 0.4 – 1.1 – 1.0
-41 – – – -57 86 86 75 -89 186 186 157 157 113 113 83 83 83 83 71 71 57 57 57 51 38 35 35 106
-47 – – – -63 -81 -81 -93 -106 -143 -143 -179 -179 -226 -226 -259 -259 -263 -263 -278 -278 -295 -295 -295 -311 -325 -329 -329 -345
– 9.7 9.7 9.7 28 28 28 28 42 29 29 35 55 35 35 34 54 35 35 35 35 35 44 35 37 38 59 38 45

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?